In a significant development for the rare disease community, Cellares and Papillon Therapeutics have announced a strategic collaboration aimed at…
Read More

In a significant development for the rare disease community, Cellares and Papillon Therapeutics have announced a strategic collaboration aimed at…
Read More
Swedish Orphan Biovitrum (Sobi) has received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) concerning…
Read More
VERTANICAL has announced a significant milestone in its development of VER-01, an investigational non-opioid therapeutic candidate for chronic low back…
Read More
Telomir Pharmaceuticals has taken a significant stride in its mission to combat advanced and metastatic triple-negative breast cancer (TNBC) by…
Read More